You are here

Dr Xuan Banh

BSc, MBBS (QLD), FRACP

Gastroenterologist

Dr Xuan Banh

Dr Xuan Banh is an Australian-trained gastroenterologist who graduated from the University of Queensland and subsequently underwent physician training at multiple hospitals including the Princess Alexandra Hospital, Logan Hospital and QEII Jubilee Hospital. She also undertook post-fellowship training in Luminal Interventional Endoscopy at the Alfred Hospital in Melbourne.

She is a fellow in the Royal Australian College of Physicians and is a member of the Gastroenterology Society of Queensland.

Dr Xuan Banh is a general gastroenterologist with an interest in all aspects of gastroenterology. She has a special interest in interventional luminal endoscopy, including therapeutic dilatations, endoscopic mucosal resection (EMR) of large polyps, endoscopic dilatations and small bowel investigations including balloon enteroscopy and capsule endoscopy.

Qualifications

  • BSc / MBBS, FRACP

Professional Memberships

  • Royal Australasian College of Physicians (RACP).
  • Gastroenterology Society of Queensland (GESQ).

Positions

  • Staff Specialist, Department of Gastroenterology, Queen Elizabeth II Jubilee Hospital.
  • Visiting Medical Officer, St Andrew’s War Memorial Hospital.
  • Visiting Medical Officer, The Wesley Hospital.
  • Visiting Medical Officer, Westside Taringa Hospital.
  • Visiting Medical Officer, St Andrew’s Hospital Ipswich.

Publications

Original Articles

  • Gupta S, Sidhu M, Banh X, Bradbear J, Byth K, Hourigan LF, Raftopoulos S, Bourke MJ (2020). A prospective multicentre study of per-oral endoscopic myotomy (POEM) for achalasia in Australia. Med J Aust.
  • Patel PJ, Cheng JC, Banh X, Gracen L, Radford-Smith D, Hossain F, Horsfall LU, Hayward KL, Williams S, Johnson T, Brown NN, Saad N, Stuart KA, Russell AW, Valery PC, Clouston AD, Irvine KM, Bernard A, Powell EE. (2020) Clinically Significant Fibrosis Is Associated With Longitudinal Increases in Fibrosis-4 and Nonalcoholic Fatty Liver Disease Fibrosis Scores. Clin Gastroenterol Hep.
  • Patel PJ, Hossain F, Horsfall LU, Banh X, Hayward KL, Williams S, Johnson T, Brown NN, Saad N, Valery PC, Irvine KM, Clouston AD, Stuart KA, Russell AW, Powell EE. (2018) Controlled Attenuation Parameter in NAFLD Identifies Risk of Suboptimal Glycaemic and Metabolic Control. J Diabetes Complications.
  • Patel PJ, Hossain F, Horsfall L, Banh X, Hayward K, Williams S, Johnson T, Bernard A, Brown NN, Lampe G, Buck L, Saad N, Russell AW, Valery P, Irvine KM, Clouson A, Stuart KA,  Rosenberg W, Powell EE. (2018) A pragmatic approach identifies a high rate of NAFLD with advanced fibrosis in diabetes clinics and at-risk populations in primary care. Hepatology Communications.
  • Patel PJ, Banh X, Horsfall LU, Hayward KL, Hossain F, Johnson T, Stuart KA, Brown NN, Saad N, Clouston A, Irvine KM, Russell AW, Valery PC, Williams S, Powell EE. (2017) Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis. Internal Med J.
  • Irvine KM, Banh X, Gadd VL, Wojcik KIK, Ariffin JK, Jose S, Lukowski S, Baillie GJ, Sweet MJ, Powell EE. (2016) CRIg defines a novel population of phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites. JCI Insight